JPRN-UMIN000021554
尚未招募
未知
A feasibility study of combination with oral fluoropyrimidine, oxaliplatin and trastuzumab for HER2-positive advanced or recurrent gastric cancer - A feasibility study of combination with oral fluoropyrimidine, oxaliplatin and trastuzumab for HER2-positive advanced or recurrent gastric cancer
agoya University Hospital0 个研究点目标入组 20 人2016年4月1日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- HER2-positive unresectable advanced gastric cancer
- 发起方
- agoya University Hospital
- 入组人数
- 20
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\. HER2 negative 2\. Uncontrolled diabetes 3\. Uncontrolled hypertension 4\. Unstable angina pectoris 5\. Synchronous cancers 6\. Systemic infection requiring treatment 7\. Fever above 38 degree Celsius 8\. A possibility of pregnancy or during pregnancy, or lactating women 9\. Continuous systemic administration of steroids 10\. Resistance to trastuzumab 11\. Peripheral neuropathy Grade 2 or more 12\. Oxaliplatin allergy
结局指标
主要结局
未指定
相似试验
已完成
1 期
Phase I/II Study of Combination Therapy of Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin in Patients with Unresectable and/or Recurrent Advanced Gastric Cancer Step 2: low dose cisplatin given twice a week + S-1unresectable or recurrent gastric cancerJPRN-C000000282Japanese Foundation for Multidisciplinary Treatment of Cancer52
已完成
不适用
Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agentJPRN-UMIN000009999Department of Urology, University of the Ryukyus50
尚未招募
2 期
To study the effectiveness of Tablet Fluuconazole in superficial fungal infection (Tinea Corporis)CTRI/2020/05/025442Dr ASVINI J
已完成
不适用
The effect of the intra oral slow release fluoride device in remineralisation of enamel and dentine in situ.ISRCTN21720818Department of Health25
已完成
不适用
Clinical evaluation of the effect of fluoride–releasing elastomeric chains on the number of Streptococcus mutans in orthodontic patients.Dental caries.Other specified symptoms and signs involving the digestive system and abdomenIRCT201110317959N1Office of Vice Chancellor for Research of Shiraz University of Medical Sciences60